As the largest institutional investors in Europe, insurers represent a major market for asset managers, but they also bring Solvency II-shaped baggage. In this Q&A, Erik Vynckier breaks down the building blocks to winning the custom of European insurers
US insurance is on a collision course with one of its biggest risk capital changes in years. It is a significant change for the long-term asset allocation strategy of US insurers and could herald a reshuffle in the fixed income portfolio. Sarfraz Thind reports.
The arrival of Solvency II has already begun to reshape the relationship between insurers and asset managers, with optional add-ons becoming mandatory deliverables for insurance clientele. David Walker looks at the changing relationship between insurers and their investment partners.
The industry's opportunity to recommend changes to EU regulation in a post-Brexit world has delivered a comprehensive criticism of the MA. David Walker and Asa Gibson report.
Scor Global Investments' chief executive François de Varenne explains to Asa Gibson how the group's asset management policy has moved away from its conservative, post-crisis stance.
If insurers can overcome historical bias and some regulatory stumbling blocks, absolute return funds could offer uncorrelated and attractive returns, with little cost under Solvency II, according to Melanie Rijkenberg
The life sector must adapt to survive under Solvency II with low investment yields, says the former chief investment officer of Alliance Bernstein, Erik Vynckier. He talks to David Walker
Solvency II and asset diversification strategies have added a mountain of data to the insurance investment process, prompting insurers to look at new initiatives to tackle the issue. Sarfraz Thind reports.
The poor performance of hedge funds has led some insurers to slash their allocation, but the asset class has the potential to produce yield in difficult markets, as Asa Gibson reports
Paul Tang, rapporteur for the regulation on securitisations, urges the European Commission to ease the charges for insurers investing in simple, transparent and standardised (STS) securitisations, and rules out the introduction of compulsory third-party certification for such products demanded by the industry. He speaks to Hugo Coelho